All Blogs / Industries / Medical / Pharmaceutical / New

Street Prices of Rx Brand-Name Drugs Increase as Much as 400%!

Drug companies always claim that the wholesale price of drugs is not an good indicator of what patients, insurers, and the government pay. So a new study published in JAMA Dermatology looked at the retail prices 19 brand-name prescription...Show More Summary

Take the DCI Economic Reports Survey...and Win a Free Report!

I want to know what you think of Drug Channels Institute's (DCI) economic reports and how I can improve them. Click here to take the DCI Economic Reports Survey What's in it for you? Well, just answer a few brief questions—the survey...Show More Summary

Up Scope! Pharma, Periscope and Some Regulatory Questions

Back in June in a posting about the new (relatively) live streaming capability brought to use by Periscope. The app, acquired by Twitter prior to its launch early in 2015, allows you to live stream content from where you are to … Continue reading ?

Expanded Access Programs 2016

Expanded Access Programs 2016February 23-24, 2016 | Washington, legislation is quickly paving the path for easier patient access to experimental, unapproved drugs. CBI’s Expanded Access Programs...Show More Summary

Increased DTC Advertising and Rising Drug Prices - Is There a Causal Link?

There's no denying two facts: FACT #1: Spending on prescription drugs is increasing dramatically. The Chicago Tribune, quoting data from IMS health, reported (here) that "Spending [in 2014] rose 13 percent [vs. 2013], the biggest jump...Show More Summary

Weekly Roundup 11.20.15

The cranberries have been bought and so have the clementines. The cream cheese for the pumpkin cheese cake is in the fridge along with the sausage and green apples for the cornbread stuffing. The turkey is on order for pickup … Continue reading ?

After the Valeant-Philidor Blowup, PBMs Clamp Down on Network Pharmacies

The initial fallout from the Valeant-Philidor kerfluffle has hit the pharmacy industry. Over the past few weeks, the major pharmacy benefit managers (PBMs) have begun dropping pharmacies from their networks. Some PBMs are also reminding...Show More Summary

HIV Celebrity Diagnosis – What’s Changed. What Hasn’t.

On Monday news came out saying that actor Charlie Sheen would be announcing that he had HIV during a TODAY Show interview that would occur on Tuesday. In addition he issued an open letter about his announcement and HIV status. … Continue reading ?

Bernie Sanders Blasts FDA Commish Nominee Califf on Drug Reimportation

Senator Bernie Sanders laid into FDA Commissioner nominee Robert Califf during yesterday's Senate hearing. Here's a snippet of his comments regarding reimportation of Rx drugs as a means to lower drug prices - an issue of importance to 91% of voters (for more on that, read this): Bernie Sanders to Robert Califf: "You're Not the One."

Independent Pharmacy Economics: Profits Steady, but Sales Down (Maybe)

Time for my annual look at independent pharmacy owners’ business economics, drawn from the recently released 2015 National Community Pharmacists Association (NCPA) Digest, Sponsored by Cardinal Health. Here's the press release: NCPAShow More Summary

sPCMA Business Forum

A MESSAGE FROM sPCMAConnect with Specialty Pharmacy’s Most Influential Leaders The sPCMA Business Forum attracts the highest number of executives and decision makers from PBMs and the nation's largest specialty pharmacies of any industry conference. Show More Summary

How Kim Kardashian Got Hired to Shill for Diclegis by "Auditioning" in a Nutraceutical Ad

You may recall that the FDA sent a letter to Duchesnay Inc. because an Instagram post by Kim Kardashian promoting the company's morning sickness drug Diclegis violated the law (read "Kim Kardashian's Diclegis Instagram Post Raises Issues"). Some...Show More Summary

Pharma Digital Investment is Increasing, But Still Only 3-6% of the Total Promotional Spend

Every year I get a call from a market analyst asking me what the trend is for digital marketing spending in the pharmaceutical industry. He wants to know if the profits of health websites, which depend on drug display ads, will increase or decrease next year. Who am I to judge? I only report the data I glean from various sources. Show More Summary

Copyright © 2015 Regator, LLC